Nurmohamed M, Choy E, Charles-Schoeman C, et al. Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials. ACR 2017, abstract 2966.
Anti-IL17A verbetert de uitkomsten van PsA
mrt 2017 | Arthritis psoriatica